创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

WEI Qing, WEN Xiaodong. Research Progress in anti-Colorectal Cancer of Natural Compounds Based on AMPK/mTOR Signalling Pathway[J]. Progress in Pharmaceutical Sciences, 2019, 43(10): 793-800.
Citation: WEI Qing, WEN Xiaodong. Research Progress in anti-Colorectal Cancer of Natural Compounds Based on AMPK/mTOR Signalling Pathway[J]. Progress in Pharmaceutical Sciences, 2019, 43(10): 793-800.

Research Progress in anti-Colorectal Cancer of Natural Compounds Based on AMPK/mTOR Signalling Pathway

  • Colorectal cancer, one of the most common malignant tumors of the digestive system, is a major public health threat worldwide. At present, the main treatment for colorectal cancer is surgery combined with radiotherapy and chemotherapy, but it is often accompanied by various side effects. At the same time, some natural compounds with good anti-colorectal cancer activity are expected to become new drug candidates for colorectal cancer treatment. AMP-dependent protein kinase (AMPK), a central hub of intracellular energy metabolism, can regulate tumor cell growth and proliferation by inhibiting its downstream target mammalian rapamycin target protein (mTOR). In recent years, more and more studies have shown that some natural products exert their anti-colorectal cancer activity by regulating the AMPK/mTOR pathway. This article focuses on the role of AMPK/mTOR signalling pathway in colorectal cancer with a review of the research progress of anti-colorectal cancer natural products regulating AMPK/mTOR signalling pathway.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return